“one around an sglt2 inhibitor and another one around nicotinamide riboside”
Main Takeaways:
- SGLT2 inhibitors and nicotinamide riboside are being studied for their effects on longevity.
- These substances are part of recent findings in longevity research.
- Nicotinamide riboside is popular as a supplement for NAD precursor.
Notes: Mention of upcoming publication of research findings.
Tone: Anticipatory
Relevance: 4/5
“although the human data on the sglt2 inhibitors is also remarkable and i think that's the sort of that's the theme here right is you have a great itp outcome and of course the human data are not for longevity but they're right again they suffer the the limitations of all human studies namely that they're being used in a subset of the population that might not be the subset of interest but you know the impact on kidney failure all-cause mortality heart failure is pretty impressive”
Main Takeaways:
- SGLT2 inhibitors have shown remarkable outcomes in human studies, though not specifically for longevity.
- These studies have limitations, such as being conducted on specific subsets of the population.
- Impacts observed include reductions in kidney failure, all-cause mortality, and heart failure.
Notes: Discussion on the effectiveness and limitations of human studies on SGLT2 inhibitors.
Tone: Cautious
Relevance: 4/5
“UK biobank people taking sglt2 Inhibitors seem to have lower all cause mortality so there may be a better case for a longevity effect”
Main Takeaways:
- SGLT2 inhibitors may reduce overall mortality according to UK Biobank data.
- Suggests potential longevity benefits from SGLT2 inhibitors.
Notes: Comparing the potential longevity effects of SGLT2 inhibitors and metformin.
Tone: Speculative
Relevance: 4/5
“you can take Metformin or an sgt2 inhibitor or a glp1 Agonist and you will directly impact those things you could take uh a pcsk9 inhibitor or a Statin or bidic acid you will directly impact those disease processes you will delay the onset of those diseases and you will reduce the mortality associated with them”
Main Takeaways:
- Certain medications can directly impact and delay the onset of diseases.
- Using specific drugs can reduce mortality associated with chronic diseases.
Notes: Speaker discussing pharmacological interventions for longevity.
Tone: Analytical
Relevance: 5/5
“I take a few right so I take some that are disease specific right so I take a pcsk9 inhibitor I take bidic acid uh I take an sglt2 inhibitor um and then I take at least one that is purely just uh based on the belief of its capacity and Juro protection which is rrap ayin and um and also the SG the sglt2 inhibitor I think is probably just broadly geroprotective.”
Main Takeaways:
- The speaker takes several supplements, some for disease-specific reasons and others for general health protection.
- Mentions taking a PCSK9 inhibitor, bidic acid, and an SGLT2 inhibitor.
- Rapamycin is taken based on its believed capacity for neuroprotection and general geroprotection.
Notes: Discussing personal supplement regimen
Tone: Informative
Relevance: 5/5
No comments yet.